Effect of antidiabetic drug on endothelial function
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2018
Price : $35 *
At a glance
- Drugs Linagliptin (Primary) ; Voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms EFFORT
- 18 Mar 2018 Status changed from active, no longer recruiting to completed.
- 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Sep 2017 New trial record